Company Biopharm International Srl with Fiscal Code 7962932
recorded a turnover of 2024 of
1.649.536,
with a net profit of
498.507
and having an average number of employees of
4.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Biopharm International Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
22.014
31.196
320.816
54.215
44.965
229.947
372.749
907.520
903.859
1.649.536
Total Income - EUR
22.017
31.425
322.816
54.230
45.794
231.590
374.595
908.014
916.023
1.649.756
Total Expenses - EUR
16.566
21.924
163.522
60.890
68.236
122.357
256.621
481.517
599.469
1.057.735
Gross Profit/Loss - EUR
5.451
9.501
159.295
-6.659
-22.441
109.234
117.975
426.497
316.554
592.021
Net Profit/Loss - EUR
4.790
8.565
151.420
-7.202
-22.891
106.986
114.674
417.599
289.085
498.507
Employees
1
1
1
1
2
1
2
4
4
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 83.5%, from 903.859 euro in the year 2023, to 1.649.536 euro in 2024.
The Net Profit increased by 211.038 euro, from 289.085 euro in 2023, to 498.507 in the last year.
Check the financial reports for the company - Biopharm International Srl
Financial Rating - BIOPHARM INTERNATIONAL SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Biopharm International Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Biopharm International Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Biopharm International Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Biopharm International Srl - CUI 7962932
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
8.130
8.942
90.427
69.291
45.134
66.035
73.403
77.283
194.726
301.975
Current Assets
22.536
158.471
84.879
86.762
79.498
233.869
339.930
753.473
856.990
1.181.616
Inventories
2.459
36.787
151
4.695
4.723
1.165
11.623
62.278
253.170
166.282
Receivables
13.855
488
478
14.271
4.526
196.212
59.101
485.956
427.104
691.654
Cash
6.222
121.196
84.251
67.796
70.249
36.492
269.206
205.239
176.716
323.679
Shareholders Funds
17.028
8.609
159.884
149.748
68.501
174.188
284.999
419.593
707.406
764.908
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
13.681
158.825
15.714
6.788
56.470
126.769
129.488
413.587
347.727
723.408
Income in Advance
0
0
0
0
0
0
589
0
252
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.181.616 euro in 2024 which includes Inventories of
166.282 euro, Receivables of
691.654 euro and cash availability of
323.679 euro.
The company's Equity was valued at
764.908 euro, while total Liabilities amounted to
723.408 euro.
Equity increased by 61.455 euro, from 707.406 euro in 2023, to 764.908 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Biopharm International Srl